These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

794 related items for PubMed ID: 20191893

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier.
    Silva GA.
    Surg Neurol; 2007 Feb; 67(2):113-6. PubMed ID: 17254859
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Has nanotechnology led to improved therapeutic outcomes?
    Bosselmann S, Williams RO.
    Drug Dev Ind Pharm; 2012 Feb; 38(2):158-70. PubMed ID: 22191583
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Internal benchmarking of a human blood-brain barrier cell model for screening of nanoparticle uptake and transcytosis.
    Ragnaill MN, Brown M, Ye D, Bramini M, Callanan S, Lynch I, Dawson KA.
    Eur J Pharm Biopharm; 2011 Apr; 77(3):360-7. PubMed ID: 21236340
    [Abstract] [Full Text] [Related]

  • 8. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
    Son SJ, Bai X, Lee SB.
    Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
    [Abstract] [Full Text] [Related]

  • 9. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ, Mousa SA.
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Review: nanoparticles in delivery of cardiovascular drugs.
    Arayne MS, Sultana N, Qureshi F.
    Pak J Pharm Sci; 2007 Oct; 20(4):340-8. PubMed ID: 17604260
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Liposomal nanomedicines.
    Fenske DB, Cullis PR.
    Expert Opin Drug Deliv; 2008 Jan; 5(1):25-44. PubMed ID: 18095927
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Polymeric nanoparticles - targeted drug delivery systems for treatment of CNS disorders and their possible endocrine disrupting activities.
    Rollerova E, Scsukova S, Jurcovicova J, Mlynarcikova A, Szabova E, Kovriznych J, Zeljenkova D.
    Endocr Regul; 2011 Jan; 45(1):49-60. PubMed ID: 21314211
    [Abstract] [Full Text] [Related]

  • 19. [Recent development of targeted drug delivery system].
    Zhou PJ, Deng SQ, Gong QF.
    Yao Xue Xue Bao; 2010 Mar; 45(3):300-6. PubMed ID: 21351504
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.